Winter 1999 (January 25-26, 1999)

Discuss a proposed framework on how to evaluate the potential public health risk from microbial effects associated with the use of antimicrobials in food animals.

• VMAC 1999 Meeting Materials
• 1999 VMAC Briefing Materials (PDF - 2.7MB)
• Minutes - 1999 VMAC (PDF - 487KB)
• VMAC Transcript - January 25, 1999 (PDF - 1.7MB)
• VMAC Transcript - January 25, 1999 with signed certificate (PDF - 12.1MB)
• VMAC Transcript - January 26, 1999 (PDF - 1.2MB)
• VMAC Transcript - January 26, 1999 with signed certificate (PDF - 3.2MB)
• VMAC Meeting Rescheduled for January
• Framework Document Available
• Framework Document
• Questions - 1999 VMAC
• FR Notice of Availability of Guidance: Evaluation of the Human Health Impact of the Microbial Effects of Antimicrobial New Animal Drugs Intended for Use in Food-Producing Animals

Fall/Winter 1998 (December 10-11, 1998)

Discuss a proposed framework on how to evaluate the potential public health hazard from resistant pathogens and resistance genes associated with the use of antimicrobials in food animals. POSTPONED

• VMAC Meeting Rescheduled for January
• Framework Document Available
• VMAC Meeting Postponed
• Opportunity for Public Participation in December VMAC Meeting
• FDA Veterinary Medicine Advisory Committee to Meet

November 1997

To discuss issues relating to the manufacture of animal drugs

• Transcript - November 12, 1997 (PDF - 1.2MB)
• Transcript - November 13, 1997 (PDF - 585KB)

Spring 1997 (May 14, 1997)

Define clinical ineffectiveness and describe how a veterinarian would determine it exists under the proposed regulations for the Animal Drug Use Clarification Act (AMDUCA).

• VMAC 1997 Meeting Transcripts
• VMAC 1997 Meeting Minutes
• Minutes of May 1997 VMAC (PDF - 36KB)
• Transcript - May 13, 1997 (PDF - 1.9MB)
• Transcript - May 14, 1997 (PDF - 891KB)

Spring 1995 (May 10-11, 1995)

• VMAC Transcript - May 10, 1995 (PDF - 7.4MB)
• VMAC Transcript - May 11, 1995 (PDF - 5.5MB)

Spring 1993 - May 6-7, 1993

• VMAC Transcript - May 6, 1993 (PDF - 15.6MB)
• VMAC Transcript - May 7, 1993 (PDF - 10.2MB)

Spring 1993 - March 31, 1993

Persons using assistive technology may not be able to fully access information in these documents. For assistance, please call 240-276-9300.

• Summary Minutes (PDF - 265KB)
• Introductory Remarks by Dr. Guest (PDF - 161KB)
• Human Food Safety Evaluation of New Animal Drugs (PDF - 102KB)
• Milk Monitoring for Drug Residues (PDF - 226KB)
• Posilac Product Information (PDF - 441KB)
• Statement of Congressman Bernard Sanders on BGH (PDF - 274KB)
• Testimony on Potential Animal and Human Health Effects of rbGH Use - Consumer Policy Institute (PDF - 700KB)
• Statement of D.S. Kronfeld, Professor of Veterinary Medicine, Virginia Tech (PDF - 723KB)
• Presentation of Walter P. Hobgood, Monsanto Company (PDF - 241KB)
• Presentation of R.J. Collier, Monsanto Company (PDF - 3.7MB)
• Remarks by Virginia V. Weldon, Monsanto Company (PDF - 285KB)
• Statement of Hardie Farms, Inc. (PDF - 206KB)
• Statement of John C. Simms (PDF - 135KB)
• Statement of National Mastitis Council (PDF - 65KB)
• Presentation of Richard Burroughs, DVM (PDF - 656KB)
• Statement of Center for Science in the Public Interest (PDF - 150KB)
• Statement of J. Russell Bishop, University of Wisconsin-Madison (PDF - 239KB)
• Statement of Tim Atwater, Rural Vermont (PDF - 1.2MB)
• Statement of the American Medical Association (PDF - 135KB)
• Statement of Food Animal Concerns Trust (PDF - 76KB)
• Statement of the Humane Society of the United States (PDF - 230KB)
• Questions/BST (PDF - 27KB)